Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results    crawled time : 16:20    save search
Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
Published: 2024-04-07 (Crawled : 16:20) - prnewswire.com
IONS | $40.64 -0.42% -0.42% 850K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
positive for results study
Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
Published: 2024-02-24 (Crawled : 16:20) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
disease urticaria results
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
Published: 2024-01-07 (Crawled : 16:20) - globenewswire.com
RXST | $51.6 -0.29% -0.29% 240K twitter stocktwits trandingview |
| Email alert Add to watchlist
financial results
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
Published: 2024-01-07 (Crawled : 16:20) - globenewswire.com
AKYA | $3.81 -1.04% -1.05% 170K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | Email alert Add to watchlist
year financial results
Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2023
Published: 2023-12-31 (Crawled : 16:20) - prnewswire.com
ISDAF | $5.13 29.59% 100 twitter stocktwits trandingview |
n/a
 | Email alert Add to watchlist
ELLO | $14.92 -0.8% 75 twitter stocktwits trandingview |
Utilities
 | Email alert Add to watchlist
ISDAY | $48.5 8.61% 330 twitter stocktwits trandingview |
Finance and Insurance
 | Email alert Add to watchlist
results
Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
Published: 2023-12-10 (Crawled : 16:20) - globenewswire.com
JSPR | $21.61 -6.89% -7.4% 65K twitter stocktwits trandingview |
| Email alert Add to watchlist
presentation positive cell aml therapeutics results study
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
Published: 2023-11-05 (Crawled : 16:20) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
MLTX | $42.19 -0.14% -0.14% 530K twitter stocktwits trandingview |
| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nanobody active results phase 2
Lilly's Retevmo® (selpercatinib) Phase 3 Results in RET Fusion-Positive Non-Small Cell Lung Cancer and RET-Mutant Medullary Thyroid Cancer Both Published in The New England Journal of Medicine and Presented in a Presidential Symposium at ESMO Congress 2023
Published: 2023-10-21 (Crawled : 16:20) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
retevmo lung congress symposium cancer cell thyroid results
Crinetics Topline Results from Paltusotine Phase 3 PATHFNDR-1 Study
Published: 2023-09-10 (Crawled : 16:20) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
topline results study
Compass Digital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 – Marketscreener.com
Published: 2023-08-04 (Crawled : 16:20) - spacfeed.com
ALPP | $0.7505 -1.5% -1.52% 27K twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
CDAQ | $10.78 0.09% 24K twitter stocktwits trandingview |
n/a
 | Email alert Add to watchlist
six acquisition results
Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of ANX007 as a Differentiated Treatment for Geographic Atrophy
Published: 2023-07-30 (Crawled : 16:20) - globenewswire.com
ANNX | $4.57 2.93% 2.84% 1.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
anx007 treatment trial potential results
MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody® sonelokimab in hidradenitis suppurativa
Published: 2023-06-25 (Crawled : 16:20) - globenewswire.com
MLTX | $42.19 -0.14% -0.14% 530K twitter stocktwits trandingview |
| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nanobody positive results milestone phase 2
Lilly's SURMOUNT-2 results published in The Lancet show tirzepatide achieved a mean weight reduction of 15.7% at the highest dose (15 mg) in adults with obesity or overweight and type 2 diabetes
Published: 2023-06-24 (Crawled : 16:20) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
obesity lancet diabetes results show tirzepatide
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
Published: 2023-06-24 (Crawled : 16:20) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
zp8396 pharma sessions trial results
Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress
Published: 2023-06-17 (Crawled : 16:20) - globenewswire.com
VERA | $37.96 -3.85% -4.0% 1.4M twitter stocktwits trandingview |
Professional, Scientific, and T...
 | Email alert Add to watchlist
association renal presentation origin positive week trial therapeutics results igan
Gracell Biotechnologies Presents Longer-Term Results for FasTCAR-T GC012F in B-Cell Non-Hodgkin’s Lymphoma at EHA2023, Highlighting 100% Overall Response Rate
Published: 2023-06-10 (Crawled : 16:20) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
gc012 response results
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
Published: 2023-05-06 (Crawled : 16:20) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K twitter stocktwits trandingview |
| Email alert Add to watchlist
iris glaucoma sciences results
AbbVie Announces Late-Breaking Results of Study Evaluating 52-Week Efficacy and Safety of SKYRIZI® (risankizumab) in Plaque Psoriasis Patients With a Prior Suboptimal Response to IL-17 Inhibitor Therapy
Published: 2023-03-18 (Crawled : 16:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
il-17 skyrizi abbvie psoriasis response therapy results study
Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session
Published: 2023-03-04 (Crawled : 16:20) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cardiology positive results
IDT Corporation to Report First Quarter FY2023 Results
Published: 2022-12-17 (Crawled : 16:20) - idt.net
IDT | $36.68 2.09% 0.0% 69K twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
fy2023 report corporation results
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.